MALDI reveals membrane lipid profile reversion in MDX mice

Neurobiology of Disease

Volumn 36, Issue 2, 2009, Pages 252-258

  Benabdellah, Farida ^a   Yu, Hua ^b   Brunelle, Alain ^a   Laprévote, Olivier ^a,c   De La Porte, Sabine ^b  

^a CNRS   (France)

^b LABORATOIRE DE NEUROBIOLOGIE CELLULAIRE ET MOLÉCULAIRE   (France)

^c Centre Universitaire des Saints Pères   (France)

Author keywords

Duchenne muscular dystrophy; In situ profiling; MALDI MS; mdx; Molsidomine; NO donor

Indexed keywords

MOLSIDOMINE; PHOSPHATIDYLCHOLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; IMMUNOHISTOLOGY; LIPID ANALYSIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE STRUCTURE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; MEMBRANE LIPIDS; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; PHOSPHATIDYLCHOLINES; REGENERATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 70349781660     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.07.013     Document Type: Article

References (29)

1. Anderson J.E. A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells. Mol. Biol. Cell 11 (2000) 1859-1874
2. Bakkar N., Wang J., Ladner K.J., Wang H., Dahlman J.M., Carathers M., Acharyya S., Rudnicki M.A., Hollenbach A.D., and Guttridge D.C. IKK/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J. Cell Biol. 180 (2008) 787-802
3. Barton E.R., Morris L., Kawana M., Bish L.T., and Toursel T. Systemic administration of l-arginine benefits mdx skeletal muscle function. Muscle Nerve 32 (2005) 751-760
4. Blake D.J., Weir A., Newey S.E., and Davies K.E. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev. 82 (2002) 291-329
5. Brenman J.E., Chao D.S., Gee S.H., McGee A.W., Craven S.E., Santillano D.R., Wu Z., Huang F., Xia H., Peters M.F., Froehner S.C., and Bredt D.S. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell 84 (1996) 757-767
6. Bulfield G., Siller W.G., Wight P.A., and Moore K.J. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 1189-1192
7. Chaubourt E., Fossier P., Baux G., Leprince C., Israël M., and De La Porte S. Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy. Neurobiol. Dis. 6 (1999) 499-507
8. Cole M.J., and Enke C.G. Direct determination of phospholipid structures in microorganisms by fast atom bombardment triple quadrupole mass spectrometry. Anal. Chem. 63 (1991) 1032-1038
9. Gillis J.M. Membrane abnormalities and Ca homeostasis in muscles of the mdx mouse, an animal model of the Duchenne muscular dystrophy: a review. Acta Physiol. Scand. 156 (1996) 397-406
10. Han X., and Gross R.W. Structural determination of picomole amounts of phospholipids via electrospray ionization tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 6 (1995) 1202-1210
11. Hnia K., Gayraud J., Hugon G., Ramonatxo M., De La Porte S., Matecki S., and Mornet D. l-arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers. Am. J. Pathol. 172 (2008) 1509-1519
12. Hsu F.F., and Turk J. Electrospray ionization/tandem quadrupole mass spectrometric studies on phosphatidylcholines: the fragmentation processes. J. Am. Soc. Mass Spectrom. 14 (2003) 352-363
13. Hulbert A.J. Life, death and membrane bilayers. J. Exp. Biol. 206 (2003) 2303-2311
14. Karas M., Bachmann D., Bahr U., and Hillenkamp F. Matrix-assisted ultraviolet laser desorption of non-volatile compounds. Int. J. Mass Spectrom. 78 (1987) 53-58
15. Karpati G., Carpenter S., Morris G.E., Davies K.E., Guerin C., and Holland P. Localization and quantification of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. J. Neuropath. Exp. Neur. 52 (1993) 119-128
16. Kunze D., Reichmann G., Egger E., Olthoff D., and Döhler K. Fatty acid pattern of lipids in normal and dystrophic human muscle. Eur. J. Clin. Invest. 5 (1975) 471-475
17. Lee K.H., Baek M.Y., Moon K.Y., Song W.K., Chung C.H., Ha D.B., and Kang M.S. Nitric oxide as a messenger molecule for myoblast fusion. J. Biol. Chem. 269 (1994) 14371-14374
18. Love D.R., Hill D.F., Dickson G., Spurr N.K., Byth B.C., Marsden R.F., Walsh F.S., Edwards Y.H., and Davies K.E. An autosomal transcript in skeletal muscle with homology to dystrophin. Nature 339 (1989) 55-58
19. Niebrόj-Dobosz I., and Hausmanowa-Petrusewicz I. The involvement of oxidative stress in determining the severity and progress of pathological processes in dystrophin-deficient muscles. Acta Biochim. Pol. 52 (2005) 449-452
20. Pastoret S., and Sebille A. Mdx mice show progressive weakness and muscle deterioration with age. J. Neurol. Sci. 129 (1995) 97-105
21. Pearce P.H., Johnsen R.D., Wysocki S.J., and Kakulas B.A. Muscle lipids in Duchenne muscular dystrophy. Aust. J. Exp. Biol. Med. 59 (1981) 77-90
22. Porter J.D., Khanna S., Kaminski H.J., Sunil Rao J., Merriam A.P., Richmonds C.R., Leahy P., Li J., Guo W., and Andrade F.H. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum. Mol. Genet. 11 (2002) 263-272
23. Ségalat L., Grisoni K., Archer J., Vargas C., Bertrand A., and Anderson J.E. CAPON expression in skeletal muscle is regulated by position, repair, NOS activity, and dystrophy. Exp. Cell Res. 302 (2005) 170-179
24. Squire S., Raymackers J.M., Vandebrouck C., Potter A., Tinsley J., Fisher R., Gillis J.M., and Davies K.E. Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system. Hum. Mol. Genet. 11 (2002) 3333-3344
25. Stoeckli M., Chaurand P., Hallahan D.E., and Caprioli R.M. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat. Med. 7 (2001) 493-496
26. Tahallah N., Brunelle A., De La Porte S., and Laprévote O. Lipid mapping in human dystrophic muscle by cluster-time-of-flight secondary ion mass spectrometry imaging. J. Lipid Res. 49 (2008) 438-454
27. Touboul D., Piednoël H., Voisin V., De La Porte S., Brunelle A., Halgand F., and Laprévote O. Changes of phospholipid composition within the dystrophic muscle by matrix-assisted laser desorption/ionization mass spectrometry imaging. Eur. J. Mass Spectrom. 10 (2004) 657-664
28. Voisin V., and De La Porte S. Therapeutic strategies for Duchenne and Becker dystrophies. Int. Rev. Cytol. 240 (2004) 1-30
29. Voisin V., Sébrié C., Matecki S., Yu H., Gillet B., Ramonatxo M., Israël M., and De La Porte S. L-arginine improves dystrophic phenotype in mdx mice. Neurobiol. Dis. 20 (2005) 123-130